Clinical trial
Bortezomib and Celecoxib in Treating Patients With Advanced Solid Tumors
NCT00290680 · Medical University of South Carolina, Other · Completed
Key facts
| NCT number | NCT00290680 |
|---|---|
| Title | Bortezomib and Celecoxib in Treating Patients With Advanced Solid Tumors |
| Official title | Phase I Trial of Bortezomib (VELCADE™) and Celecoxib in Patients With Advanced Solid Tumors |
| Lead sponsor | Medical University of South Carolina, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | bortezomib, celecoxib |
| Enrollment | 36 |
| Start date | Mar 1, 2005 |
| Primary completion | Jan 1, 2009 |
| Completion | Jan 1, 2009 |
| First posted | Feb 13, 2006 |
| Last update posted | Apr 10, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: